Qualigen Therapeutics, Inc. Annual Share-based Payment Arrangement, Expense in USD from 2014 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Qualigen Therapeutics, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2014 to 2023.
  • Qualigen Therapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2024 was $33.1K, a 63.9% decline year-over-year.
  • Qualigen Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $1.1M, a 80% decline from 2022.
  • Qualigen Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $5.48M, a 3.6% increase from 2021.
  • Qualigen Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $5.29M.
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $1.1M -$4.39M -80% Jan 1, 2023 Dec 31, 2023 10-K 2024-04-08
2022 $5.48M +$190K +3.6% Jan 1, 2022 Dec 31, 2022 10-K 2024-04-08
2021 $5.29M Jan 1, 2021 Dec 31, 2021 10-K 2023-05-02
2017 $895K -$464K -34.1% Jan 1, 2017 Dec 31, 2017 10-K 2018-03-19
2016 $1.36M -$1.54M -53% Jan 1, 2016 Dec 31, 2016 10-K 2018-03-19
2015 $2.89M +$2.19M +309% Jan 1, 2015 Dec 31, 2015 10-K 2017-02-27
2014 $707K Jan 1, 2014 Dec 31, 2014 10-K 2016-03-21
* An asterisk sign (*) next to the value indicates that the value is likely invalid.